Neutrophil-to-lymphocyte ratio as an early marker of outcomes in patients with advanced non-small-cell lung cancer treated with nivolumab

Aya Nakaya, Takayasu Kurata, Hiroshige Yoshioka, +7

International Journal of Clinical Oncology

The gold compound auranofin induces apoptosis of human multiple myeloma cells through both down-regulation of STAT3 and inhibition of NF-κB activity

Aya Nakaya, M. Sagawa, Akihiro Muto, +3

Leukemia Research

InflammationNf-κb ActivityAnti-inflammatoryApoptosisImmunology +8

Immune checkpoint inhibitor re-challenge in patients with advanced non-small cell lung cancer

Maiko Niki, Aya Nakaya, Takayasu Kurata, +5

Oncotarget

Delayed HBV reactivation in rituximab-containing chemotherapy: How long should we continue anti-virus prophylaxis or monitoring HBV-DNA?

Aya Nakaya, Shinya� Fujita, Atsushi� Satake, +8

Leukemia Research

Delayed Hbv ReactivationOncologyRituximab-containing ChemotherapyViral PersistenceAntiviral Therapy +6

Does the Hematopoietic Cell Transplantation Specific Comorbidity Index (HCT-CI) Predict Transplantation Outcomes? A Prospective Multicenter Validation Study of the Kanto Study Group for Cell Therapy

Aya Nakaya, Takehiko Mori, Masatsugu Tanaka, +14

Biology of Blood and Marrow Transplantation

Retrospective analysis of bevacizumab‐induced hypertension and clinical outcome in patients with colorectal cancer and lung cancer

Aya Nakaya, Takayasu Kurata, Takashi Yokoi, +7

Cancer Medicine

Impact of CRAB Symptoms in Survival of Patients with Symptomatic Myeloma in Novel Agent Era

Aya Nakaya, Shinya� Fujita, Atsushi� Satake, +8

Hematology Reports

Associations between acute GVHD-related biomarkers and endothelial cell activation after allogeneic hematopoietic stem cell transplantation

Shosaku� Nomura, Kazuyoshi� Ishii, Shinya� Fujita, +3

Transplant Immunology

Pembrolizumab-induced autoimmune encephalitis in a patient with advanced non-small cell lung cancer: A case report

Maiko Niki, Aya Nakaya, Takayasu Kurata, +6

Molecular and Clinical Oncology

Lung Cancer TreatmentAutoimmune DiseaseAllergyImmune Checkpoint InhibitorsPembrolizumab Treatment +13

Neutrophil-to-lymphocyte ratio (NLR) fails to predict outcome of diffuse large B cell lymphoma

Yoshiko� Azuma, Aya Nakaya, Shinya� Fujita, +10

Leukemia Research Reports